TownSquare Capital’s Elevance Health ELV Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2025
Q3
Sell
-532
Closed -$207K 450
2025
Q2
$207K Sell
532
-6,638
-93% -$2.67M 0.02% 578
2025
Q1
$3.12M Buy
7,170
+803
+13% +$322K 0.03% 467
2024
Q4
$2.35M Sell
6,367
-2,360
-27% -$988K 0.03% 532
2024
Q3
$4.54M Buy
8,727
+517
+6% +$276K 0.05% 321
2024
Q2
$4.45M Buy
8,210
+2,118
+35% +$1.12M 0.06% 291
2024
Q1
$3.16M Buy
6,092
+3,836
+170% +$1.91M 0.05% 346
2023
Q4
$1.06M Buy
2,256
+66
+3% +$30.5K 0.02% 575
2023
Q3
$954K Buy
2,190
+1,577
+257% +$715K 0.02% 572
2023
Q2
$272K Buy
613
+125
+26% +$57.7K 0.01% 921
2023
Q1
$224K Buy
+488
New +$232K ﹤0.01% 905

Other funds holding ELV

TownSquare Capital's ELV Position: Q3 2025 in Review

TownSquare Capital sold out of Elevance Health (ELV) in Q3 2025, closing a stake of 532 shares — an estimated $207K sold.

TownSquare Capital first reported a position in ELV in Q1 2023 and held it in 10 quarters. The position peaked at $4.54M in Q3 2024. 1,510 funds tracked by Wall St. Rank hold ELV as of Q3 2025.

  • TownSquare Capital reported no remaining Elevance Health position as of Q3 2025 after selling out during the quarter.
  • TownSquare Capital sold 532 Elevance Health shares in Q3 2025, an estimated $207K.
  • TownSquare Capital first reported a position in Elevance Health in Q1 2023 and held it in 10 quarters.
  • TownSquare Capital's Elevance Health position peaked at $4.54M in Q3 2024.
  • 1,510 funds tracked by Wall St. Rank held Elevance Health as of Q3 2025.

Based on TownSquare Capital's 13F filing for Q3 2025, filed 3 Nov 2025.